A randomized trial of telehealth mindfulness-based cognitive therapy and cognitive behavioral therapy groups for adolescents with mood or attenuated psychosis symptoms.


Journal

Journal of consulting and clinical psychology
ISSN: 1939-2117
Titre abrégé: J Consult Clin Psychol
Pays: United States
ID NLM: 0136553

Informations de publication

Date de publication:
Apr 2023
Historique:
pmc-release: 01 04 2024
medline: 15 5 2023
pubmed: 18 1 2023
entrez: 17 1 2023
Statut: ppublish

Résumé

There is substantial evidence that cognitive behavioral therapy (CBT) and mindfulness-based cognitive therapy (MBCT) improve symptoms and functioning in adults with mood and psychotic disorders. There has been little work directly comparing these treatments among adolescents with early-onset mood or psychosis symptoms. We conducted a randomized controlled trial comparing remotely administered group CBT to group MBCT for adolescents (ages 13-17) with a mood disorder or attenuated psychosis symptoms. Adolescents attended nine sessions over 2 months; their parents attended parallel groups focused on the same skill practices. Participants were assessed for psychiatric symptoms and functioning at posttreatment and 3 months posttreatment. Sixty-six youth ( The beneficial effect of both treatments in a group telehealth format is encouraging. Due to our limited sample, future research should investigate whether adolescents' history of adversity and treatment preferences replicate as treatment moderators for youth with mood or psychosis symptoms. (PsycInfo Database Record (c) 2023 APA, all rights reserved).

Identifiants

pubmed: 36649157
pii: 2023-37459-001
doi: 10.1037/ccp0000782
pmc: PMC10175156
mid: NIHMS1864957
doi:

Banques de données

ClinicalTrials.gov
['NCT05070052']

Types de publication

Randomized Controlled Trial Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

234-241

Subventions

Organisme : NIMH NIH HHS
ID : K23 MH124015
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH123575
Pays : United States
Organisme : NIMH NIH HHS
ID : R34 MH117200
Pays : United States
Organisme : NIMH NIH HHS
ID : U01 MH124639
Pays : United States

Références

Schizophr Res. 2019 Mar;205:10-14
pubmed: 29779964
Annu Rev Psychol. 2006;57:285-315
pubmed: 16318597
Br J Psychiatry. 1978 Nov;133:429-35
pubmed: 728692
Am J Prev Med. 2015 Sep;49(3):354-61
pubmed: 26296440
Psychol Med. 2014 Feb;44(3):449-68
pubmed: 23521867
J Am Acad Child Adolesc Psychiatry. 2018 Oct;57(10):755-763.e4
pubmed: 30274650
Front Psychiatry. 2019 Oct 31;10:797
pubmed: 31736811
Psychiatr Serv. 2016 Apr 1;67(4):456-9
pubmed: 26567937
Cogn Behav Pract. 2020 May;27(2):202-214
pubmed: 33519172
World Psychiatry. 2018 Jun;17(2):133-142
pubmed: 29856558
Br J Clin Psychol. 2005 Jun;44(Pt 2):227-39
pubmed: 16004657
Schizophr Bull. 2003;29(4):703-15
pubmed: 14989408
Eur Psychiatry. 2019 Apr;57:33-45
pubmed: 30658278
Behav Ther. 2019 Jan;50(1):225-240
pubmed: 30661562
Schizophr Res. 2011 Jun;129(1):42-6
pubmed: 21511440
J Clin Psychiatry. 2010 Mar;71(3):313-26
pubmed: 20331933
J Am Acad Child Adolesc Psychiatry. 2020 Jul;59(7):842-855
pubmed: 31676392
Int J Nurs Stud. 2021 Mar;115:103848
pubmed: 33383273
J Clin Child Adolesc Psychol. 2008 Jan;37(1):62-104
pubmed: 18444054
J Consult Clin Psychol. 2014 Apr;82(2):275-86
pubmed: 24294837
Early Interv Psychiatry. 2018 Feb;12(1):3-14
pubmed: 28782283
Eval Program Plann. 1979;2(3):197-207
pubmed: 10245370

Auteurs

Marc J Weintraub (MJ)

Department of Psychiatry, Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California, Los Angeles.

Danielle Denenny (D)

Department of Psychiatry, Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California, Los Angeles.

Megan C Ichinose (MC)

Department of Psychiatry, Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California, Los Angeles.

Jamie Zinberg (J)

Department of Psychiatry, Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California, Los Angeles.

Georga Morgan-Fleming (G)

Department of Psychiatry, Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California, Los Angeles.

Monica Done (M)

Department of Psychiatry, Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California, Los Angeles.

Robin D Brown (RD)

Department of Psychiatry, Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California, Los Angeles.

Carrie E Bearden (CE)

Department of Psychiatry, Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California, Los Angeles.

David J Miklowitz (DJ)

Department of Psychiatry, Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California, Los Angeles.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH